Quantum Genesis AI Corp.
About Quantum Genesis AI Corp.
Quantum Genesis AI Corp. (OTC: QGAI), formerly Quantumzyme Corp., is a biotransformation company focused on advancing enzyme-based solutions for pharmaceutical manufacturing. It utilizes customer-centric research to enhance enzyme activity by applying quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts. The company aims to improve efficiency, reduce waste, and support production while advancing next-generation technologies at the intersection of artificial intelligence, computational modeling, and scientific innovation. It was incorporated in 2015 and is based in San Diego, California.
- 🔗 Quantum Genesis AI net loss hits $4,379,525 | QGAI Quarterly Report (10-Q)
- 🔗 Quantum Genesis AI net loss hits $4,379,525 | QGAI Quarterly Report (10-Q)
- 🔗 Quantum Genesis AI Corp. Issues Statement Regarding OTC Markets Caveat Emptor Designation
- 🔗 Quantum Genesis AI Corp. (QGAI) Stock Price, News, Quote & History - Yahoo Finance
- 🔗 Quantum Genesis AI Issues Clarification Regarding Research Activities and Intellectual Property | Nasdaq
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $5M via Reg A offering with undisclosed investors.
- Renamed from Quantumzyme Corp. to Quantum Genesis AI Corp. in February 2026.
- Reports net loss of $4,379,525 in recent quarterly filing.
- Focuses on AI and quantum mechanics for pharmaceutical biocatalysts.
- Subject to OTC Markets Caveat Emptor designation.
Ask StreetZero about Quantum Genesis AI Corp.
Put our AI to work on this deal.
Similar companies
Other Other deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account